tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

JSPR Stock Latest News

Jasper Therapeutics initiated with an Outperform at BMO Capital
The FlyJasper Therapeutics initiated with an Outperform at BMO Capital
16d ago
JSPR
Jasper: First patient dosed in ETESIAN clinical study of briquilimab in asthma
PremiumThe Fly
Jasper: First patient dosed in ETESIAN clinical study of briquilimab in asthma
19d ago
JSPR
Jasper Therapeutics Advances in Antibody Therapy Development
PremiumCompany Announcements
Jasper Therapeutics Advances in Antibody Therapy Development
1M ago
JSPR
Jasper Therapeutics reports Q3 EPS ($1.24), consensus ($1.07)
PremiumThe Fly
Jasper Therapeutics reports Q3 EPS ($1.24), consensus ($1.07)
1M ago
JSPR
Jasper Therapeutics commences open-label extension study of chronic urticarias
PremiumThe Fly
Jasper Therapeutics commences open-label extension study of chronic urticarias
2M ago
JSPR
Jasper Therapeutics management to meet virtually with Jefferies
PremiumThe FlyJasper Therapeutics management to meet virtually with Jefferies
2M ago
JSPR
Jasper shows ‘good responses’ for briquilimab in CIndU, says Stifel
Premium
The Fly
Jasper shows ‘good responses’ for briquilimab in CIndU, says Stifel
2M ago
CLDX
JSPR
Morning Movers: Longboard Pharmaceuticals surges following deal to be acquired
Premium
The Fly
Morning Movers: Longboard Pharmaceuticals surges following deal to be acquired
2M ago
BA
APP
Jasper Therapeutics repoirts data from its SPOTLIGHT study of briquilimab
PremiumThe Fly
Jasper Therapeutics repoirts data from its SPOTLIGHT study of briquilimab
2M ago
JSPR
Jasper concerns driven by Celldex data ‘overdone,’ says Stifel
PremiumThe Fly
Jasper concerns driven by Celldex data ‘overdone,’ says Stifel
3M ago
CLDX
JSPR
Jasper announces Health Canada clearance of trial application of briquilimab
PremiumThe Fly
Jasper announces Health Canada clearance of trial application of briquilimab
3M ago
JSPR
Block, GE HealthCare initiated: Wall Street’s top analyst calls
PremiumThe Fly
Block, GE HealthCare initiated: Wall Street’s top analyst calls
3M ago
X
CL
Jasper Therapeutics initiated with an Outperform at JMP Securities
PremiumThe FlyJasper Therapeutics initiated with an Outperform at JMP Securities
3M ago
JSPR
Jasper Therapeutics price target lowered to $68 from $70 at RBC Capital
Premium
The Fly
Jasper Therapeutics price target lowered to $68 from $70 at RBC Capital
4M ago
JSPR
Jasper Therapeutics reports Q2 EPS (97c), consensus ($1.09)
Premium
The Fly
Jasper Therapeutics reports Q2 EPS (97c), consensus ($1.09)
4M ago
JSPR
Jasper Therapeutics, Inc. (JSPR) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Jasper Therapeutics, Inc. (JSPR) Q2 Earnings Cheat Sheet
5M ago
JSPR
3 Best Stocks to Buy Now, 7/9/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/9/2024, According to Top Analysts
6M ago
INST
JSPR
Jasper Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
Jasper Therapeutics initiated with a Buy at BTIG
6M ago
CLDX
JSPR
Jasper Therapeutics initiated with a Buy at Stifel
PremiumThe Fly
Jasper Therapeutics initiated with a Buy at Stifel
6M ago
CLDX
JSPR
Jasper Therapeutics Board Changes and New Director’s Arrival
PremiumCompany AnnouncementsJasper Therapeutics Board Changes and New Director’s Arrival
6M ago
8K
JSPR
Jasper Therapeutics presents data from preclinical briquilimab study
Premium
The Fly
Jasper Therapeutics presents data from preclinical briquilimab study
6M ago
JSPR
Jasper Therapeutics Endorses Equity Plans and Strengthens Leadership
Premium
Company Announcements
Jasper Therapeutics Endorses Equity Plans and Strengthens Leadership
6M ago
8K
JSPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >